1 / 4

France Myocardial Infarction Market

France Myocardial Infarction Market

farazp70
Download Presentation

France Myocardial Infarction Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research France Myocardial Infarction Market Size, Share, Growth, Industry Analysis Report and Forecast to 2025 Request a free sample of our report on France Myocardial Infarction Market: https://www.omrglobal.com/request-sample/france-myocardial-infarction-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

  2. France myocardial infarction (MI) market is estimated to grow considerably, at a CAGR of around 3.9% during the forecast period. The rise in lifestyle-oriented diseases such as CHD, CVD, stroke, and other heart diseases is creating a huge demand for cardiology surgeries in France. High consumption of alcohol, smoking, high level of animal fat consumption, serum total cholesterol, and high-density lipoprotein cholesterol concentrations are the key factors responsible for the high risk of heart attacks among the population of the country. As a result, the individual is more prone to MI and other heart diseases. Hypertension, high blood pressure, obesity, diabetes, dyslipidemia, and over-weight are the key factors that are responsible for stroke, CVD, CHD, and other heart diseases. Get Sample Copy of France Myocardial Infarction Market at:https://www.omrglobal.com/request- sample/france-myocardial-infarction-market The companies which are contributing to the growth of France myocardial infarction market include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Novartis AG, GlaxoSmithKline PLC, Koninklijke Philips N.V., Medtronic PLC, Merck KGaA, and Sanofi SA. The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks. Based on the device, the market is segmented into a left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end- user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes. For More Information, get A full report of France Myocardial Infarction Market is available at: https://www.omrglobal.com/industry-reports/france-myocardial-infarction-market The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in April 2019, Sanofi SA announced that its product Praluent has been approved by the US FDA. Praluent intends to decrease the risk of heart attack, stroke, and unstable angina that requires the hospitalization of adults. This product approval enabled the company to broaden its product and service portfolio. Market Segmentation France Myocardial Infarction Market by Type •Non-ST-elevation myocardial infarction (NSTEMI) •ST-elevation myocardial infarction (STEMI) •Silent Heart Attacks France Myocardial Infarction Market by Device

  3. •Left Ventricular Assist Device (LVAD) •Pacemaker •Catheters •Implantable Cardioverter-Defibrillator (ICD) •Others (Stent Graft) France Myocardial Infarction Market by Diagnosis •Electrocardiography (ECG) •Chest X-Ray •Computed Tomography (CT Scan) •Echocardiography •Others (Blood Test) France Myocardial Infarction Market by Treatment •Medication •Analgesics •Thrombolytic •Antiplatelet Agents •Glycoprotein IIb/IIIa Inhibitors •Others (Beta-Adrenergic Blockers) •Surgery •Angioplasty •Bypass Surgery •Heart Transplant France Myocardial Infarction Market by End-User •Hospital & Clinics •Ambulatory Surgical Centers •Research Institutes For more customized data, request for report customization @https://www.omrglobal.com/report- customization/france-myocardial-infarction-market About Orion Market Research

  4. Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visithttps://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related